RSS-Feed abonnieren

DOI: 10.1055/s-0045-1810433
Outcomes of Transjugular Intrahepatic Portosystemic Shunt Procedures in a Very-Low-Volume Institution: A Retrospective Single-Center Study

Abstract
Purpose
This study aimed to evaluate the outcomes of transjugular intrahepatic portosystemic shunt (TIPSS) procedures performed in a very-low-volume center over 4 years, focusing on procedural success, complication rates, and clinical effectiveness in managing portal hypertension and related complications.
Materials and Methods
A retrospective analysis was conducted of those who underwent TIPSS at our institution from October 2020 to October 2024. Inclusion criteria were no prior TIPSS or liver surgery and available follow-up data. Data collected included patient demographics, portal hypertension etiology, and procedural details. Success was assessed in technical, hemodynamic, and clinical categories, with complication and readmission rates analyzed.
Results
Ten patients (six male, four female; median age 45.5 years, range 12–74) underwent TIPSS between October 2020 and October 2024. TIPSS indications included refractory ascites (40%) and variceal bleeding (60%), with all procedures elective except one emergency case for acute variceal bleeding. Technical success was achieved in 90%, with one unsuccessful shunt placement in a patient due to extensive hepatic vein and vena cava thrombosis. The mean portosystemic pressure gradient (PSG) decreased from 27 ± 3.32 to 8.56 ± 1.74 mm Hg, with hemodynamic success achieved in all patients (PSG ≤ 12 mm Hg). Clinical success was observed with no rebleeding or large-volume paracentesis required within 30 days postprocedure.
Conclusion
TIPSS can be effectively performed in a very-low-volume center, yielding favorable outcomes with manageable complications, provided it is conducted by experienced physicians following proper protocols.
Publikationsverlauf
Artikel online veröffentlicht:
30. Juli 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol 2019; 70 (01) 151-171
- 2 GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019 [published correction appears in Lancet. 2020 Nov 14;396(10262):1562. doi: 10.1016/S0140-6736(20)32226-1.]. Lancet 2020; 396 (10258): 1204-1222
- 3 Saad WE. The history and future of transjugular intrahepatic portosystemic shunt: food for thought. Semin Intervent Radiol 2014; 31 (03) 258-261
- 4 Büttner L, Aigner A, Pick L. et al. 25 years of experience with transjugular intrahepatic portosystemic shunt (TIPS): changes in patient selection and procedural aspects. Insights Imaging 2022; 13 (01) 73
- 5 Richter GM, Palmaz JC, Nöldge G. et al. Der transjuguläre intrahepatische portosystemische Stent-Shunt (TIPSS). Eine neue nichtoperative, perkutane Methode. [The transjugular intrahepatic portosystemic stent-shunt. A new nonsurgical percutaneous method] Radiologe 1989; 29 (08) 406-411
- 6 Rössle M, Richter GM, Noeldge G. et al. Der intrahepatische portosystemische Shunt. Erste klinische Erfahrungen bei Patienten mit Leberzirrhose. [The intrahepatic portosystemic shunt. Initial clinical experiences with patients with liver cirrhosis] Dtsch Med Wochenschr 1989; 114 (40) 1511-1516
- 7 Rösch J, Hanafee WN, Snow H. Transjugular portal venography and radiologic portacaval shunt: an experimental study. Radiology 1969; 92 (05) 1112-1114
- 8 Colapinto RF, Stronell RD, Gildiner M. et al. Formation of intrahepatic portosystemic shunts using a balloon dilatation catheter: preliminary clinical experience. AJR Am J Roentgenol 1983; 140 (04) 709-714
- 9 Sarwar A, Zhou L, Novack V. et al. Hospital volume and mortality after transjugular intrahepatic portosystemic shunt creation in the United States. Hepatology 2018; 67 (02) 690-699
- 10 Gaba RC, Khiatani VL, Knuttinen MG. et al. Comprehensive review of TIPS technical complications and how to avoid them. AJR Am J Roentgenol 2011; 196 (03) 675-685
- 11 Suhocki PV, Lungren MP, Kapoor B, Kim CY. Transjugular intrahepatic portosystemic shunt complications: prevention and management. Semin Intervent Radiol 2015; 32 (02) 123-132
- 12 Boyvat F, Aytekin C, Harman A, Ozin Y. Transjugular intrahepatic portosystemic shunt creation in Budd-Chiari syndrome: percutaneous ultrasound-guided direct simultaneous puncture of the portal vein and vena cava. Cardiovasc Intervent Radiol 2006; 29 (05) 857-861
- 13 Boyvat F, Harman A, Ozyer U, Aytekin C, Arat Z. Percutaneous sonographic guidance for TIPS in Budd-Chiari syndrome: direct simultaneous puncture of the portal vein and inferior vena cava. AJR Am J Roentgenol 2008; 191 (02) 560-564
- 14 Wu HM, Huang SQ, Wan YM, Li YH, Xu Y. Clinical outcomes of transjugular intrahepatic portosystemic shunt (Tips) creation using Fluency versus Viatorr stent-grafts: a single-centre retrospective study. Cardiovasc Intervent Radiol 2022; 45 (05) 552-562
- 15 Schultheiss M, Bettinger D, Sturm L. et al. Comparison of the covered self-expandable Viatorr CX stent with the covered balloon-expandable BeGraft peripheral stent for transjugular intrahepatic portosystemic shunt (TIPS) creation: a single-centre retrospective study in patients with variceal bleeding. Cardiovasc Intervent Radiol 2022; 45 (05) 542-549
- 16 Li W, Liu M, Guan S. et al. Comparison of outcomes for transjugular intrahepatic portosystemic shunt creation: Viatorr versus Fluency versus a bare stent/Fluency stent combination. CVIR Endovasc 2024; 7 (01) 76
- 17 Palmaz JC, Garcia F, Sibbitt RR. et al. Expandable intrahepatic portacaval shunt stents in dogs with chronic portal hypertension. AJR Am J Roentgenol 1986; 147 (06) 1251-1254
- 18 Bilbao JI, Quiroga J, Herrero JI, Benito A. Transjugular intrahepatic portosystemic shunt (TIPS): current status and future possibilities. Cardiovasc Intervent Radiol 2002; 25 (04) 251-269
- 19 American College of Radiology, Society of Interventional Radiology, Society for Pediatric Radiology. ACR-SIR-SPR practice parameter for the creation of a transjugular intrahepatic portosystemic shunt (TIPS). Am Coll Radiol 2017; 1-25
- 20 Córdoba J. New assessment of hepatic encephalopathy. J Hepatol 2011; 54 (05) 1030-1040
- 21 Cannella R, Tselikas L, Douane F. et al. Imaging-guided interventions modulating portal venous flow: Evidence and controversies. JHEP Rep Innov Hepatol 2022; 4 (07) 100484
- 22 Hamid RS, Tanveer-ul-haq, Azeemuddin M, Sajjad Z, Chishti I, Salam B. Transjugular intrahepatic portosystemic shunt (TIPS); review of initial experience at Aga Khan University Hospital. J Pak Med Assoc 2011; 61 (04) 336-339
- 23 Perello MP, Mur JP, Vives MS. et al. Long-term follow-up of transjugular intrahepatic portosystemic shunt (TIPS) with stent-graft. Diagn Interv Radiol 2019; 25 (05) 346-352
- 24 Barrera Gutierrez JC, Zullo M, Sclair S, Tavri S. Predictors of duration of transjugular intrahepatic portosystemic shunt (TIPS) procedure: a retrospective single-center study. Cureus 2024; 16 (07) e65776
- 25 Tripathi D, Helmy A, Macbeth K. et al. Ten years' follow-up of 472 patients following transjugular intrahepatic portosystemic stent-shunt insertion at a single centre. Eur J Gastroenterol Hepatol 2004; 16 (01) 9-18
- 26 Valentin N, Korrapati P, Constantino J, Young A, Weisberg I. The role of transjugular intrahepatic portosystemic shunt in the management of portal vein thrombosis: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 2018; 30 (10) 1187-1193
- 27 Lopera JE. Role of emergency transjugular intrahepatic portosystemic shunts. Semin Intervent Radiol 2005; 22 (04) 253-265
- 28 Patch D, Nikolopoulou V, McCormick A. et al. Factors related to early mortality after transjugular intrahepatic portosystemic shunt for failed endoscopic therapy in acute variceal bleeding. J Hepatol 1998; 28 (03) 454-460
- 29 Jalan R, John TG, Redhead DN. et al. A comparative study of emergency transjugular intrahepatic portosystemic stent-shunt and esophageal transection in the management of uncontrolled variceal hemorrhage. Am J Gastroenterol 1995; 90 (11) 1932-1937
- 30 Kim HK, Kim YJ, Chung WJ. et al. Clinical outcomes of transjugular intrahepatic portosystemic shunt for portal hypertension: Korean multicenter real-practice data. Clin Mol Hepatol 2014; 20 (01) 18-27
- 31 Pateria P, Jeffrey GP, Garas G. et al. Transjugular intrahepatic portosystemic shunt: Indications, complications, survival and its use as a bridging therapy to liver transplant in Western Australia. J Med Imaging Radiat Oncol 2017; 61 (04) 441-447
- 32 Rössle M. TIPS: 25 years later. J Hepatol 2013; 59 (05) 1081-1093
- 33 Crenshaw WB, Gordon FD, McEniff NJ. et al. Severe ascites: efficacy of the transjugular intrahepatic portosystemic shunt in treatment. Radiology 1996; 200 (01) 185-192
- 34 D'Amico G, Luca A, Morabito A, Miraglia R, D'Amico M. Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis. Gastroenterology 2005; 129 (04) 1282-1293
- 35 Ferral H, Gamboa P, Postoak DW. et al. Survival after elective transjugular intrahepatic portosystemic shunt creation: prediction with model for end-stage liver disease score. Radiology 2004; 231 (01) 231-236
- 36 Gschwantler M, Gebauer A, Vavrik J. et al. Acute and chronic complications after implantation of a transjugular intrahepatic portosystemic shunt–a prospective study in 53 patients. Z Gastroenterol 1997; 35 (11) 999-1005